25周年を記念 1999-2024
*3年間で¥ 153396、たったの¥ 61358
フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Filed by ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...
Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed...
Eclipsys Corporation (NASDAQ: ECLP), The Outcomes Company®, will be participating in the William Blair & Company’s 30th Annual...
Filed by ECLIPSYS CORPORATION pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the...
Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Eclipsys...
Filed by ECLIPSYS CORPORATION Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12...
Filed by ECLIPSYS CORPORATION Pursuant to Rule 425 under the Securities Act of...
Filed by ECLIPSYS CORPORATION pursuant to Rule 425 under the Securities Act of 1933 and deemed filed...
Kendall Law Group is investigating Eclipsys Corp. (NASDAQ: ECLP) for shareholders in connection with the proposed sale of...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約